The Valley Desk

NCT00004037 · Interventional trial

Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer

Overall registry status Terminated

Phase 2

Conditions Ovarian Cancer, Primary Peritoneal Cavity Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov